Table 3. Modularity analysis.
The list of pathways enriched in modules for PBMCs (relapse vs. remission).
| Module ID | Pathway | p-value |
|---|---|---|
| M1 | hsa04612 : antigen processing and presentation | 6.6E–8 |
| hsa05340 : primary immunodeficiency | 2.7E–2 | |
| hsa05332 : graft-versus-host disease | 3.0E–2 | |
| hsa02010 : ABC transporters | 3.4E–2 | |
| M7 | hsa04115 : p53 signaling pathway | 3.5E–3 |
| hsa04110 : cell cycle | 1.2E–2 | |
| M8 | hsa04623 : cytosolic DNA-sensing pathway | 2.5E–4 |
| hsa04622 : RIG-I-like receptor signaling pathway | 5.2E–4 | |
| hsa04620 : toll-like receptor signaling pathway | 1.5E–3 | |
| M9 | hsa04120 : ubiquitin mediated proteolysis | 2.3E–2 |
| M10 | hsa03050 : proteasome | 1.3E–9 |
| M11 | hsa03040 : spliceosome | 1.0E–3 |
| hsa04350 :TGF-beta signaling pathway | 4.1E–2 |